OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
66 hedge funds and large institutions have $61M invested in OncoMed Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
66
Holding in Top 10
–
Calls
$2K
Puts
–
Top Buyers
| 1 | +$537K | |
| 2 | +$282K | |
| 3 | +$223K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$188K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$181K |
Top Sellers
| 1 | -$2.09M | |
| 2 | -$2.01M | |
| 3 | -$987K | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$570K |
| 5 |
PP
PDT Partners
New York
|
-$242K |